These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 22924995)

  • 1. Hippocampal agenesis in an individual who engaged in violent criminal behaviors after discontinuing carbamazepine and paroxetine treatment.
    Hanada H; Akiyoshi J; Kanehisa M; Ishitobi Y; Tsuru J; Tanaka Y; Shimomura T; Kawano Y
    J Forensic Sci; 2013 Jan; 58(1):255-8. PubMed ID: 22924995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the serotonin 1A, 2A, 2C, 3A, and 3B and serotonin transporter gene polymorphisms on the occurrence of paroxetine discontinuation syndrome.
    Murata Y; Kobayashi D; Imuta N; Haraguchi K; Ieiri I; Nishimura R; Koyama S; Mine K
    J Clin Psychopharmacol; 2010 Feb; 30(1):11-7. PubMed ID: 20075642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome.
    Himei A; Okamura T
    CNS Drugs; 2006; 20(8):665-72. PubMed ID: 16863271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
    Yasui-Furukori N; Kaneko S
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 5-year-old boy with recurrent mania successfully treated with carbamazepine.
    Tuzun U; Zoroglu SS; Savas HA
    Psychiatry Clin Neurosci; 2002 Oct; 56(5):589-91. PubMed ID: 12193252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
    Baldwin D; Bridgman K; Buis C
    J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy.
    Huang Y; Chen W; Li Y; Wu X; Shi X; Geng D
    Psychiatry Res; 2010 Apr; 182(1):48-52. PubMed ID: 20227856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin syndrome after lithium add-on medication to paroxetine.
    Sobanski T; Bagli M; Laux G; Rao ML
    Pharmacopsychiatry; 1997 May; 30(3):106-7. PubMed ID: 9211572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to discontinuation among the three second-generation antidepressants in a naturalistic outpatient setting of depression.
    Lee YM; Lee KU
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):630-7. PubMed ID: 22176282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypersexuality in Parkinson's disease with carbamazepine--a case report.
    Bach JP; Oertel WH; Dodel R; Jessen F
    Mov Disord; 2009 Jun; 24(8):1241-2. PubMed ID: 19309760
    [No Abstract]   [Full Text] [Related]  

  • 15. A combination of carbamazepine/tiapride in outpatient alcohol detoxification. Results from an open clinical study.
    Soyka M; Morhart-Klute V; Horak M
    Eur Arch Psychiatry Clin Neurosci; 2002 Oct; 252(5):197-200. PubMed ID: 12451459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
    Bonne O; Gill JM; Luckenbaugh DA; Collins C; Owens MJ; Alesci S; Neumeister A; Yuan P; Kinkead B; Manji HK; Charney DS; Vythilingam M
    J Clin Psychiatry; 2011 Aug; 72(8):1124-8. PubMed ID: 21208596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar switching after carbamazepine withdrawal.
    Lange-Asschenfeldt C; Blaeser I; Supprian T
    Pharmacopsychiatry; 2007 Mar; 40(2):86-7. PubMed ID: 17447183
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of adjunctive antidepressant treatment for bipolar depression.
    Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME
    N Engl J Med; 2007 Apr; 356(17):1711-22. PubMed ID: 17392295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.